Shares of CareCloud jumped as much as 10.6% in pre-market trading after the healthcare IT company reported third-quarter results that beat on nearly every line, raising a pointed question: whether a micro-cap stock trading under $2 can convert one strong quarter into lasting investor confidence. CareCloud Delivers Record Quarterly Profit as Automation Pays Off, but Is a $75 Million Company Still Flying Under the Radar?
Shares of CareCloud surged 10.6% in pre-market trading to $1.99 after the healthcare technology company posted third-quarter results that showed a dramatic profitability inflection — raising a question investors in micro-cap stocks rarely get to ask: is the market still underpricing a company that just proved it can grow and widen margins at the same time?
Earnings Nearly Doubled While the Street Expected Less
CareCloud's Q3 2026 GAAP earnings per share more than doubled year over year to $0.10 , while revenue rose 9% year over year to $33.7 million . Analysts had forecast $0.12 in EPS and $33.50 million in revenue — meaning the top line edged past expectations even as per-share earnings came in slightly below the Street number. The real headline is the 54.5% jump in net income to $4.7 million, a record that suggests the company is finally converting revenue growth into bottom-line dollars, not just reinvesting every penny.
Automation Is Doing the Heavy Lifting on Margins
The quarter marks a sharp reversal from Q2, when GAAP net income fell 62% to $1.1 million and adjusted EBITDA declined 9% amid acquisition-integration costs. Q3 adjusted EBITDA jumped 27.8% to $9.9 million, signaling that CareCloud's bet on AI-powered tools for medical billing and patient communications is starting to replace manual labor costs with software. The company's AI platform for home-infusion client KabaFusion generated its first revenue during the quarter , hinting at a new, higher-margin revenue stream.
Guidance Held Steady — Conservative or Cautious?
CareCloud reaffirmed fiscal 2026 revenue guidance of $128–$132 million and GAAP EPS of $0.20–$0.23 . Nine-month revenue already sits at $96.9 million , meaning the company needs roughly $31–$35 million in Q4 to hit the range — easily achievable if Q3 trends hold. The unchanged guidance looks deliberately conservative, which could set up another beat.
A Micro-Cap Valuation With an Outsized Profitability Story
At a market value of roughly $73 million with 42.5 million shares outstanding , CareCloud trades at a price-to-sales ratio under 0.6x — a fraction of what most profitable healthcare-software peers command. Its forward price-to-earnings ratio is just 3.47 . The risk: low trading volume and a stock near its 52-week low of $1.73 suggest institutional investors haven't bought the turnaround story yet. Until they do, record profits alone may not be enough to sustainably reprice the stock.